HD-OPM Archive
Topics › Plaque, CAC & CT angiography

Keto trial showed worse plaque progression; DASH plus statins regressed plaque

Louis Nervegna · Oct 05, 2025 · ♥ 13 reactions · 3 comments · original Facebook post
Plaque, CAC & CT angiographyLow-carb, keto & carnivoreMediterranean, DASH, MIND & plant-forward diets
AI summary & key facts

Louis rebuts a keto influencer who cherry-picked a single CT image that looked like regression, arguing the study as a whole showed more plaque progression than a standard American diet. He contrasts it with the Disco-CT trial, where a DASH diet plus statins produced average regression equal to about 8 years of progression reversed in one year.

Keto propaganda vs reality

He is cherry picking one image from the study, when the study as a whole showed much WORSE plaque progression than eating the standard American diet:

facebook.com/share/v/1CGfNTeLjp

↪ Keto-CTA reanalysis: plaque progression still no better than the standard American diet

For comparison, a DASH diet plus statins (Disco-CT study) showed a major plaque regression for all participants in a study using a similar study protocol. The AVERAGE person saw the equivalent of 8 years of plaque regression in just one year:

↪ DISCO-CT: DASH diet plus statins reversed soft plaque by about 40 mm3 in a year

This is the stark difference between keto propaganda verses reality.

The image that he cherry picks happens to look like a regression— but it is well within the error range of the test itself. Changes like this on an image occur simply by repositioning a person a different way in the scanner.

That’s why you look at the study as a whole, instead of cherry picking the one image that makes it seem like you got the result that you wanted.

And that’s why you use software to objectively analyze all the images as a whole, instead of relying just on the subjective judgement of one human looking at only one image.

Research cited

#plaque#keto#dash#statins#discoct
← newer: ACC recommends broader hsCRP testing to detect low-grade infolder: Statins may protect the liver in chronic liver disease, a re →